Verastem, Inc. (VSTM) vs Zevra Therapeutics, Inc. (ZVRA)
Verastem, Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Verastem, Inc. and Zevra Therapeutics, Inc. are of similar size ($694.6M and $668.7M). Verastem, Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 11.6×. Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against 119.4%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs −231.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Zevra Therapeutics, Inc. leads on 15 and Verastem, Inc. on 2.
Valuation
Profitability
| Metric | VSTM | ZVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 86.35% | 95.46% | 65.16% |
| Operating margin | (182.57%) | 60.54% | 0.00% |
| Net margin | (231.59%) | 42.25% | 0.00% |
| Free cash flow margin | (185.31%) | 24.30% | 0.00% |
| Return on equity | (471.16%) | 34.33% | (57.72%) |
| Return on assets | (100.65%) | 20.57% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack